Equities Analysts Set Expectations for NTLA Q1 Earnings
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Intellia Therapeutics in a note issued to investors on Wednesday, March 5th. HC Wainwright analyst M. Kapoor expects that the company will post earnings of ($1.40) per share for the quarter. HC Wainwright […]
